Duke Autoimmunity in Pregnancy Registry

Rheumatoid Arthritis Clinical Trial

— DAP Registry  

Official title:

Duke Autoimmunity in Pregnancy Registry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00513591
• Other study ID #: Pro00000756
• Status: Completed
• Start date: August 2007
• Est. completion date: November 19, 2018

Study information

• Verified date: October 2019
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated.

The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune diseases, such as lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome who wish to become, or already are, pregnant. We will follow these women throughout pregnancy to better understand how their autoimmune disease affects their pregnancy, and vice versa.

Description:

Women with a systemic autoimmune disease that would be followed by a rheumatologist will be included in this study.

All women will be seen every 4-6 weeks throughout pregnancy. At each visit, women will complete a questionnaire, the physician will determine the current level of disease activity, and a blood sample will be taken. For women with lupus and healthy women, and additional visit will occur at the start of the 3rd trimester for a closer evaluation of predictors of preterm birth.

This is not an intervention study. Women will not be given experimental medication. All recommendations for treatment and monitoring will be made based on the best available data with input from the treating obstetrician.

Women in this Registry are not required to be seen by Duke Obstetrics nor to deliver at a Duke Hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 513
• Est. completion date: November 19, 2018
• Est. primary completion date: November 19, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older

• Desire for pregnancy within 6 months or currently pregnant

• Women with systemic autoimmune disease, including:

• Lupus (systemic lupus erythematosus or cutaneous lupus)

• Antiphospholipid Syndrome or positive antiphospholipid antibodies

• Rheumatoid Arthritis

• Scleroderma (systemic sclerosis)

• Sjogren's Syndrome

• Inflammatory Arthritis (including Psoriatic Arthritis and Ankylosing Spondylitis)

• Undifferentiated Connective Tissue Disease (UCTD)

• Vasculitis

• Myositis (Polymyositis or Dermatomyositis)

• Positive Ro/SSA or La/SSB antibodies

Exclusion Criteria:

• Unable to speak English

• Unable to provide informed consent

• Unable to travel to Duke University for follow-up visits

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Autoimmune Diseases
• Cutaneous Lupus
• Lupus Erythematosus, Systemic
• Pregnancy
• Rheumatoid Arthritis
• Scleroderma
• Scleroderma, Diffuse
• Scleroderma, Systemic
• Sjogren's Syndrome
• Systemic Lupus Erythematosus

Locations

Country	Name	City	State
United States	Duke University Medical Center	Durham	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
Duke University

Country where clinical trial is conducted

United States, 

External Links

•   The Duke Lupus Clinic website